Khellaf, M., Limal, N., Mahevas, M., Languille, L., Bierling, P., Michel, M., et al. (2009) Helicobacter pylori et Purpura thrombopénique immunologique (PTI): résultats d’une enquête prospective monocentrique sur la prévalence de l’infection et l’effet de l’éradication sur l’évolution du PTI. La Revue de Médecine Interne, 30, S350-S351.
https://doi.org/10.1016/j.revmed.2009.10.075

has been cited by the following article:

• TITLE: Immunologic Thrombocytopenic Purpura Associated with Helicobacter Pylori Infection: A Case Report from Senegal

  AUTHORS: Mohamed Keita, Mouhamed Dieng, Serigne Saliou Mbacké, Ibrahima Thioune, Mouhamadou Sidibé, Baidy Sy Kane

  KEYWORDS: Immunological Thrombocytopenic Purpura, Helicobacter Pylori, Corticosteroids

  JOURNAL NAME: Open Journal of Blood Diseases, Vol.12 No.4, November 28, 2022

  ABSTRACT: We present a 27-year-old female patient received for epistaxis associated with gingivorrhagia. In her medical history, she had undergone an oesogastroduodenal fibroscopy one year earlier, which revealed a bulbar ulcer with gastritis. On admission, she presented with a bleeding syndrome, an anemic syndrome with poor hemodynamic tolerance, and epigastric sensitivity. The blood count performed in the emergency on the citrate tube showed a bicy-topenia (regenerative anemia + thrombocytopenia). The HELIKIT test was positive. Thus, the hypothesis of an acute immunological thrombocytopenic purpura associated with a Helicobacter pylori infection seemed to us the most probable with a Khellaf hemorrhagic score of 8. She had benefited from a bolus of methyl prednisone: 15 mg/kg/day for 3 days then relay per os with prednisone 1 mg/kg/day (and adjuvant treatment); the eradicating treatment of Helicobacter pylori had been simultaneously started.